neoben

Introduction to neoben

Neoben is a brand name for the medicine Vinorelbine, primarily available in injection form. Neoben is used to treat certain types of cancer, such as non-small cell lung cancer and breast cancer. It helps slow or stop the spread of cancer cells in the body.

Composition of neoben

Neoben contains the active ingredient Vinorelbine, which belongs to a class of drugs called vinca alkaloids. These drugs work by disrupting the formation of microtubules, structures that help cells divide, thereby interfering with the growth of cancer cells.

Uses of neoben

• Non-small cell lung cancer
• Breast cancer

Side effects of neoben

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: severe bone marrow suppression, allergic reactions

Precautions of neoben

Neoben can cause severe bone marrow suppression, affecting blood cell production. It is contraindicated in patients with severe liver impairment and those with severe allergic reactions to it. Always consult your doctor before starting treatment with neoben.

How to Take neoben

The usual starting dose for adults is 25 to 30 mg/m², given once a week as an intravenous injection. The dose may be adjusted based on response and side effects. Follow your doctor’s advice for the correct way to use your prescribed form of neoben.

Conclusion of neoben

Neoben, containing the active ingredient Vinorelbine, is a therapeutic agent in the vinca alkaloid class used primarily for treating non-small cell lung cancer and breast cancer. It is manufactured for intravenous administration. Key highlights include its mechanism of action in disrupting cancer cell growth and its potential side effects, such as bone marrow suppression. Always consult healthcare professionals for personalized advice when using neoben.